.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Fish and Richardson
Fuji
Cantor Fitzgerald
Novartis
UBS
Cipla
Cerilliant
AstraZeneca
Argus Health

Generated: June 24, 2017

DrugPatentWatch Database Preview

Amoxapine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for amoxapine and what is the scope of amoxapine patent protection?

Amoxapine
is the generic ingredient in two branded drugs marketed by Watson Pharms Teva, Lederle, Upsher-smith Labs, and Watson Labs, and is included in thirteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for amoxapine. Four suppliers are listed for this compound.

Summary for Generic Name: amoxapine

Tradenames:2
Patents:1
Applicants:4
NDAs:13
Drug Master File Entries: see list4
Suppliers / Packagers: see list4
Bulk Api Vendors: see list52
Clinical Trials: see list2
Patent Applications: see list5,413
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:amoxapine at DailyMed

Pharmacology for Ingredient: amoxapine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lederle
ASENDIN
amoxapine
TABLET;ORAL018021-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Upsher-smith Labs
AMOXAPINE
amoxapine
TABLET;ORAL072878-001Jun 28, 1991DISCNNoNo► Subscribe► Subscribe
Watson Labs
AMOXAPINE
amoxapine
TABLET;ORAL072691-001Aug 28, 1992RXNoYes► Subscribe► Subscribe
Watson Labs
AMOXAPINE
amoxapine
TABLET;ORAL072688-001Aug 28, 1992RXNoNo► Subscribe► Subscribe
Watson Labs
AMOXAPINE
amoxapine
TABLET;ORAL072690-001Aug 28, 1992RXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: amoxapine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lederle
ASENDIN
amoxapine
TABLET;ORAL018021-002Approved Prior to Jan 1, 19823,546,226► Subscribe
Lederle
ASENDIN
amoxapine
TABLET;ORAL018021-002Approved Prior to Jan 1, 19823,681,357► Subscribe
Lederle
ASENDIN
amoxapine
TABLET;ORAL018021-003Approved Prior to Jan 1, 19823,546,226► Subscribe
Lederle
ASENDIN
amoxapine
TABLET;ORAL018021-001Approved Prior to Jan 1, 19823,546,226► Subscribe
Lederle
ASENDIN
amoxapine
TABLET;ORAL018021-002Approved Prior to Jan 1, 19823,663,696► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Boehringer Ingelheim
Johnson and Johnson
McKesson
Medtronic
Teva
Mallinckrodt
Federal Trade Commission
Moodys
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot